Study by Tioga Research supports efficacy of liposomal compound Silvidiol
Leading Edge Pharms, (LEP) a biotechnology company developing novel cannabinoid therapies and innovative delivery systems, announced the results of a Tioga Research-led study, indicating that its proprietary cannabidiol-based (CBD) pain relief and anti-inflammatory agent, Silvidiol, effectively perm